Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and how are you today? A few flurries are descending on the Pharmalot corporate campus this morning, which is a mixed bag. We would prefer balmier temperatures, but it does make for some pretty scenery. In any event, time to turn our attention to the day ahead, which is already shaping up to be a busy affair. We trust you can relate. So please join us as we reach for that needed cup of stimulation and attack the to-do list. As usual, here are some tidbits to get you started. Have a smashing day and keep us in mind if something interesting erupts... Actavis To Close Plant And Eliminate 300 Jobs (Charlotte Observer) Glaxo Drug Fails To Prevent Heart Attack Risk In Study (Bloomberg News) Dendreon Cuts More Jobs As Provenge Vaccine Sales Drop (Reuters) FDA Designates Alnylam Pharma Drug For Fast Review (Associated Press) GW Begins First Human Trial Of Cannabinoid Compound (Pharma Times) University Researchers Look In Coal Mines For Cancer Drugs (KY Forward) India Proposes Tougher Compensation Rules For Clinical Trials (Economic Times) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs